The normal criteria for reporting serve injuries applies even to COVID-19 cases. All rights reserved. Should AOE questions be sent to the health department in the electronic laboratory report messages?4. ©2020 Verizon Media. But a top career scientist at the CDC in charge of collecting and analyzing COVID-19 data from hospitals says the new reporting system ignores the agency's valuable expertise and disrupts CDC…
All rights reserved.Important conversations are happening now. The Trump administration is instructing hospitals to bypass the Centers for Disease Control and Prevention (CDC) in reporting their COVID-19 … For more information, see the Center for Medicare and Medicaid Service’s (CMS) For definitions of COVID-19 diagnostic, screening, and surveillance testing, see CDC’s Laboratory data elements may be reported in the following ways:Public health departments will submit de-identified data to CDC on a daily basis, using either Health Level 7 (HL7) messaging or the CDC-provided CSV format.Complete laboratory data must include the following data elements for state and jurisdictional health departments.The following additional demographic data elements should also be collected and reported to state or local public health departments.To protect patient privacy, any data that state and jurisdictional health departments send to CDC will be deidentified and will not include some patient-level information.
These data will contribute to understanding COVID-19’s impact and testing coverage and can contribute to the identification of supply chain issues for reagents and other materials. Each state has laws requiring certain diseases be reported at the state level, but it is voluntary for states to provide information or notifications to CDC at the federal level. Saving Lives, Protecting People1.
Before requesting a new code, search the list of Click map to view the status of electronic laboratory data conversion by state.Electronic reporting options are available to reduce the burden on providers reporting test results. Additional technical guidance on implementing the COVID-19 laboratory reporting requirement to comply with the For those COVID-19 tests that have not yet received FDA emergency use authorization, CDC encourages test developers and laboratories that use COVID-19 tests to work together to obtain appropriate and interoperable LOINC and SNOMED-CT codes for reporting purposes.LOINC codes must be used to represent the “question” a viral test asks of a specimen (e.g., does this specimen have SARS-CoV-2 RNA?
If you are a health care provider, please contact your state epidemiologist or local health department.To receive email updates about this page, enter your email address:Centers for Disease Control and Prevention. In the case of discrepant test results, the clinician should report the positive result.
800-CDC-INFODue to a high volume of inquiries, it may take longer than usual to receive a reply from CDC-INFO.
The information below outlines reporting requirements for laboratories.
CDC twenty four seven. 800-CDC-INFO
Email questions to DLSinquiries@cdc.gov. However, state health department rules and regulations apply and may differ from this general guidance.If a clinician receives COVID-19 test results from duplicate specimens that were collected in the same manner and tested with different test methods (e.g., different platforms) or in different CLIA laboratories, the clinician should not report both results. However, state health department rules and regulations apply and may differ from this general guidance.The reporting requirements differ for laboratories and research clinicians:Laboratories are not responsible for reporting these data since laboratories do not have the patient-identifying information required for compliance with reporting requirements. After hours, weekends and holidays, please follow the instructions to page the on-call physician.
For a clinical research trial approved by the Institutional Review Board (IRB), are laboratories required to report laboratory testing data from CLIA-certified COVID-19 testing (nucleic acid, antigen, or antibody) if the specimens are de-identified and results are not returned to the ordering clinician?8. However, state health department rules and regulations apply and may differ from this general guidance.In clinical trials, research clinicians who are responsible for clinical care of trial participants are responsible for linking de-identified specimen test results to participant demographic information and are required to report the positive results daily to the appropriate state or local public health department based on the patient’s residence. But a top career scientist at the CDC in charge of collecting and analyzing COVID-19 data from hospitals says the new reporting system ignores the agency's valuable expertise and disrupts CDC… CDC's Privacy Policy is available at For an IRB-approved clinical research trial, what are the requirements for reporting laboratory testing data from CLIA-certified COVID-19 testing (nucleic acid, antigen, or antibody) if the specimens are de-identified and results are being returned to the ordering clinician for patient care?
Employers must report any worker fatality within 8 hours and any amputation, loss of an eye, or hospitalization of a worker within 24 hours.
Add your voice!
Does this guidance require the reporting of all laboratory tests, including antibody tests and negative test results, at the case level?2.
CDC twenty four seven. We appreciate your patience.If you have general questions about coronavirus disease 2019 (COVID-19), please visit the You can find the most up-to-date information about coronavirus disease 2019 on CDC receives case notifications from 57 reporting jurisdictions. 800-CDC-INFO(800-232-4636), TTY: 888-232-6348 Email CDC-INFO. Note: Javascript is disabled or is not supported by your browser. Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30329 USA; 800-CDC-INFO